Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Conjunctivitis, Allergic

• A Study of TL-925 for the Treatment of Allergic Conjunctivitis
• A Study of MDI-1228_mesylate Ophthalmic Solution in Healthy Adults
• Safety and Efficacy of STALORAL® Birch 300 IR in a Paediatric Population With Birch Pollen-induced ARC w/o Asthma
• Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination in Adults With Seasonal Allergic Conjunctivitis
• Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination for the Treatment of Allergic Conjunctivitis
• Cyclosporine 0.05% Eye Drops for Vernal Keratoconjunctivitis Trial
• A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Flonase® Allergy Relief in Subjects With Allergic Conjunctivitis
• A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Claritin® Tablets 24-Hour in Subjects With Allergic Conjunctivitis
• The INVIGORATE 2 Trial: A Randomized, Double-masked, Crossover Design, Phase 3 Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Conjunctivitis
• Documentation of Efficacy of Intralymphatic Allergen Immunotherapy
• Study to Assess the Safety, Tolerability and Efficacy of Bilastine Ophthalmic Solution 0.6% in Children
• Efficacy and Toxicity of Bepotastine 1,5% PF vs Olopatadine 0,2% With BAK on Allergic Conjunctivitis Treatment
• DEXTENZA Therapy for Treatment of Allergic Conjunctivitis
• Topical Immuonosuppressant Drugs in Spring Catarrh
• Safety and Efficacy of VSJ-110 in the Treatment of Allergic Conjunctivitis in Adults With a History of Ocular Allergies
• Therapeutic Effect of Tacrosolv in Patients With Allergic Rhinoconjunctivitis
• Safety and Efficacy of Intracanalicular Dexamethasone Compared to Loteprednol Etabonate in Patients With Keratoconus
• The INVIGORATE Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Conjunctivitis.
• A Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Allergic Conjunctivitis
• Efficacy and Safety of Norketotifen in Adults With Allergic Rhinitis
• Manuka Eye Droops for Treatment of Allergy
• Safety and Efficacy of Low-dose IL-2 in Allergy to Birch Pollen
• Demonstration of Equivalence and Early Onset of a Novel Anti-allergic Nasal Spray Compared to Marketed Nasal Spray
• A Methodology Development Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis Using the Environmental Exposure Chamber
• A Methodology Development Environmental Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis
• ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic Conjunctivitis
• A Single-Center Evaluation of the Relative Efficacy of EM-100 Compared to Zaditor® (Ketotifen Fumarate Ophthalmic Solution 0.035%) and Vehicle
• A Study Evaluating Bilastine Ophthalmic Solution 0.6% in the Conjunctival Allergen Challenge (Ora-CAC®) Model
• A Novel Combined Therapy for Refractory Vernal Keratoconjunctivitis
• A Study of AK002 in Patients With Atopic Keratoconjunctivitis, Vernal Keratoconjunctivitis, and Perennial Allergic Conjunctivitis
• Evaluation of Subcutaneous Immunotherapy Towards Pollen in Children
• Effectiveness of PR013 Topical Ophthalmic Drops Compared to Vehicle for the Treatment of Allergic Conjunctivitis
• Study Evaluating the Efficacy and Safety of PRT-2761 for the Treatment of Acute and Chronic Allergic Conjunctivitis
• A Single-Center, Phase 2 Study Evaluating Bilastine Ophthalmic Solution in the CAC® Model
• Clinical Evaluation of Hylo-Dual Versus Patanol in Children With Seasonal Allergic Conjunctivitis
• A Study of ADX-102 in Subjects With Allergic Conjunctivitis
• OTX-15-002: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis
• Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo to Treat Allergic Conjunctivitis
• Efficacy of Co-administration of Bilastine and Montelukast in Patients With SARC and Asthma
• A Safety and Activity Study of NS2 in Subjects With Allergic Conjunctivitis
• Safety and Efficacy of Lastacaft® for the Prevention of Itching Associated With Allergic Conjunctivitis in Korea
• A Multi-Center Environmental Study for the Treatment of Moderate to Severe Ocular Allergic Conjunctivitis
• A Dose-response Evaluation of the SQ Tree SLIT-tablet Using an Environmental Exposure Chamber
• Topical Tacrolimus in Vernal Keratoconjunctivitis
• OTX-14-007: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis
• Molecular and Cellular Mechanism in Rhinitis Allergic Patients Treated With GRAZAX®
• The Impact of Grass SLIT Treatment on Birch Pollen Induced Allergic Rhinitis - a Pilot Evaluation
• Olopatadine Hydrochloride Ophthalmic Solution Study in Chinese Subjects
• A Single-Center Evaluation of the Anti-Inflammatory Effects of Lastacaft as Measured by In-Vivo Confocal Microscopy
• Evaluation of the Utility of an EEC for Assessing Efficacy of SIT in Pivotal Clinical Trials
• Compare Dose Regimens of AllerT, in Adults With Allergic Rhino-Conjunctivitis to Birch Pollen Studied in EEC
• Effectiveness of Olopatadine HCl Ophthalmic Solution for the Treatment of Allergic Conjunctivitis in Japan
• Study Immunology and Safety of 60-day Treatment of SQ Grass SLIT (Sublingual Immunotherapy)-Tablet in Adult Subjects With Grass Pollen-induced Allergic Rhinoconjunctivitis
• Evaluation of the Efficacy and Safety of AVANZ® Phleum Pratense in Grass Pollen-induced Allergic Rhinitis During Controlled Exposure in an Environmental Challenge Chamber
• AGN-229666 Ophthalmic Solution in Japanese Patients With Allergic Conjunctivitis
• A Multi-Center Study Evaluating the Safety of AC-170 0.24%
• A Single Center Study for the Treatment of Moderate to Severe Allergic Conjunctivitis (EBI-005-AC-1)
• AGN-229666 Ophthalmic Solution for the Treatment of Seasonal or Perennial Allergic Conjunctivitis
• Safety and Efficacy Study of AL-53817 and AL-78843 Ophthalmic Solutions for Allergic Conjunctivitis
• OTX-14-001: A Phase 2 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis
• Safety and Efficacy of Relestat Ophthalmic Solution 0.05% for Allergic Conjunctivitis in Korea
• Efficacy and Safety of Intraseasonal Specific Immunotherapy With Depiquick® Birch
• A Multi-Center, Evaluation of the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle
• The Effect of Pollen Season on Subcutaneous Allergen Immunotherapy Reactions
• Hydrocortisone Ophthalmic Ointment 0.5% for Treatment of Allergic Conjunctivitis
• Ocular Allergy Treatment Practical Impact Trial
• AGN-229666 for the Treatment of Allergic Conjunctivitis
• Double-Masked Trial of NOVA22007 (1mg/mL Ciclosporin/Cyclosporine) Versus Vehicle in Pediatric Patients With Active Severe Vernal Keratoconjunctivitis
• Efficacy and Safety of an Ophthalmic Solution in Patients With Allergic Conjunctivitis
• A Trial Evaluating Tolerability of Grazax Treatment in Combination With Antihistamine
• A Study to Evaluate the Efficacy of Lastacaft® Compared to Pataday™ and Placebo in Patients With Acute Allergic Conjunctivitis
• Evaluation of Prednisolone in a Modified Conjunctival Allergen Challenge Model
• A Six-Week Safety Study of an Investigational Ophthalmic Solution
• Confocal Analysis of Corneal Structures of Symptomatic Allergic Conjunctivitis Patients
• A Single-Center,Evaluation of the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle
• Clinical Efficacy of PRO-118 Compared With Olopatadine Hydrochloride Ophthalmic Solution in Allergic Conjunctivitis
• Evaluation of the Onset and Duration of Action of RX-10045 in Allergic Conjunctivitis
• SUBLIVAC FIX Birch Dose Tolerability/Dose Range Finding
• Non-Pharmaceutical Treatment of Seasonal Allergic Conjunctivitis
• An Evaluation of the Onset and Duration of Action of AKF-1 Ophthalmic Solution in Treating Acute Allergic Conjunctivitis
• A Multi-Center Study Evaluating the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle in the Conjunctival Allergen Challenge (CAC)
• Efficacy and Safety of PRO-118 Ophthalmic Solution in Allergic Conjunctivitis
• Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model
• Dose Range Finding Study With rBet v1-FV - in Adult Patients With Birch Pollen-Allergic Seasonal Rhinoconjunctivitis
• Efficacy and Safety of AL-4943A Ophthalmic Solution in Patients With Allergic Conjunctivitis Using the Conjunctival Allergen Challenge (CAC) Model
• A Study to Evaluate the Duration of LASTACAFT® in Acute Allergic Conjunctivitis
• Vitamin D and Grass Pollen Specific Immunotherapy
• An Open Trial to Assess the Tolerability of AVANZ Phleum Pratense Immunotherapy
• Bepreve vs. Alrex in Subjects With Moderate to Severe Allergic Conjunctivitis
• An Allergen BioCube (ABC) Study Evaluating the Efficacy of Fluticasone Propionate Nasal Spray Compared to Placebo
• Avanz Phleum Pratense Maintenance Dose
• A Study to Evaluate the Safety and Efficacy of Lotemax Ophthalmic Suspension 0.5%
• Alrex® Versus Patanol in the Treatment of Seasonal Allergic Conjunctivitis(SAC)
• Tolerability of Grazax in Patients With Hayfever in Real Life Settings
• Comparison of Tolerability Between Two Allergy Drops
• A Long-term Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis
• Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis
• The Effect of BEPREVE 1.5% on Tear Film Osmolarity and Tear Film Lipid Layer
• Comparison of the Efficacy and Tolerability of T1210 and Olopatadine Hydrochloride 0.1% in the Treatment of Seasonal Allergic Conjunctivitis
• Use of BEPREVE (Bepotastine Besilate Ophthalmic Solution) 1.5% for Allergic Conjunctivitis and Contact Lenses
• Efficacy of AC-170 for the Treatment of Allergic Conjunctivitis in the Conjunctival Allergen Challenge (CAC) Model
• Safety and Comfort of AL-4943A Ophthalmic Solution
• Effect of Different Concentrations of SPARC1102 on Allergic Conjunctivitis
• Patient Perception Study for AL-4943A
• Mapracorat Ophthalmic Formulation in Subjects With Allergic Conjunctivitis
• A Study to Evaluate the Safety and Efficacy of the QLT Proprietary Olopatadine-PPDS in Subjects With Seasonal Allergic Conjunctivitis to Ragweed in an Environmental Exposure Chamber Model.
• Assessment of Alcon's Ocular Image Quantification System
• A Single-Center, Randomized, Double-Masked, Placebo and Active Controlled, Dose-Ranging Evaluation of the Duration of Action of Brimonidine Tartrate Ophthalmic Solution in the Control of Ocular Redness Induced by Conjunctival Allergen Challenge (CAC
• A Study of Patient Perception and Quality of Life Associated With the Use of Olopatadine 0.2% in Subjects With Allergic Conjunctivitis
• Safety and Efficacy of Olopatadine Hydrochloride/Ketorolac Tromethamine Ophthalmic Solution Compared With Olopatadine Hydrochloride Ophthalmic Solution in Patients With Seasonal Allergic Conjunctivitis
• Topical Cyclosporine for Vernal Keratoconjunctivitis (VKC) in Rwanda
• Evaluation of the Effect and Tolerance of Preservative Free NAAGA on the Inflammatory Component and Symptoms of Dry Eye Syndrome in Allergic Conjunctivitis Patients
• Safety and Efficacy of Bepotastine Besilate Ophthalmic Solution in Seasonal Allergic Conjunctivitis Patients
• Patient Perceptions and Quality of Life Associated With the Use of Olapatadine 0.2% for the Treatment of Allergic Conjunctivitis
• Study Evaluating the Safety of KetoNaph Ophthalmic Solution in Healthy Volunteers
• Efficacy of AC-150 for the Treatment of Allergic Conjunctivitis in the Enviro-CAC™ Model
• Study Evaluating the Efficacy of Administration of Cyclosporine (Low Dose and High Dose) and Prednisolone Acetate Compared to Its Components and Vehicle in Patients With Allergic Conjunctivitis
• Assessing the Efficacy of Maxidex® and Patanol® for the Treatment of Allergic Conjunctivitis
• Clinical Evaluation of 0.1% Olopatadine Hydrochloride Ophthalmic Solution in Pediatric Patients
• Loteprednol Ophthalmic Base Compared to Loteprednol Ophthalmic Suspension vs Placebo in an Allergen Challenge
• Changes in Specific Immunoglobulin and Blood Basophil Activity During Subcutaneous Immunotherapy in Allergic Rhinitis
• Pharmacokinetic Study of Bilastine in Children From 2 to < 12 Years of Age With Either Allergic Rhinoconjunctivitis (AR) or Chronic Urticaria (CU)
• Efficacy Study of FK-506 and Cyclosporine in Vernal Keratoconjunctivits (VKC)
• PURETHAL Grasses Rush Study
• An Open-Label, Long-Term Study With AL-4943A Ophthalmic Solution, 0.2% in Patients With Allergic Conjunctivitis
• AL-38583 Ophthalmic Solution for Allergic Conjunctivitis Associated Inflammation
• Study of Olopatadine HCl Ophthalmic Solutions Compared to Vehicle Using the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis in Japanese Subjects
• Study With High Dose PURETHAL Mites in Allergic Rhinitis/Rhinoconjunctivitis Patients
• Study of the Effect of Fluticasone Furoate Nasal Spray on Spring Allergy Eye Symptoms
• Safety and Efficacy Study of a Eye Drop for Eye Allergy
• Efficacy and Safety Study of Cyclosporine 0.010% to Treat Atopic Keratoconjunctivitis
• Efficacy Study to Evaluate the Effectiveness of 3 Concentrations of SAR 1118 in Allergic Conjunctivitis
• To Evaluate the Efficacy of AL-38583 in the Reduction of Tear Eosinophil Count Following Conjunctival Allergen Challenge
• Multicenter Trial of Sublingual Immunotherapy With a Solution of Grass Pollen Allergen Extract in Children
• Evaluation of the Safety and Efficacy of Ketotifen 4.0% Patch as Compared to Placebo Patch, Olopatadine 0.2% Ophthalmic Solution, and Artificial Tears in the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis
• Evaluation of Efficacy of Coadministration of FOV1101-00 and Prednisolone Acetate in Patients With Mild Ongoing Ocular Allergic Inflammation
• Long-term Efficacy and Safety Study With Oralgen Grass Pollen
• Efficacy Investigation Study of Olopatadine Hydrochloride Ophthalmic Solution Using OHIO Chamber in Patients With Seasonal Allergic Rhinitis (SAR)
• A Randomised, Double-blind, Placebo Controlled Study With Oralgen Grass Pollen Rhinoconjunctivitis
• Study of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects With Epicutanoeus Allergen Administration
• Olopatadine Eye Drops and Allergy Skin Testing
• Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Acute Allergic Conjunctivitis.
• Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Allergic Conjunctivitis.
• Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model
• A Comparison of Olopatadine and Fluticasone in Patients With Allergic Conjunctivitis
• Effect of Olopatadine on Allergic Tear Mediators
• Efficacy and Safety Study of Bepotastine Besilate Ophthalmic Solution in Allergic Conjunctivitis
• Safety Study for Bepotastine Besilate Ophthalmic Solution in Normal Volunteers
• Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis
• A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis
• Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR
• A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis
• Phase III, Long-Term, Open-Label, Extension Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis
• Phase III Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis
• Efficacy and Safety of Grass Pollen Sublingual Immunotherapy
• Montelukast as a Controller of Atopic Syndrome
• Study of Two Marketed Ocular Anti-Allergy Medications in Subjects With Allergic Conjunctivitis
• Comparison of CL Wear Between Two Allergy Drops
• Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in the Treatment of Allergic Conjunctivitis
• Lactobacillus Rhamnosus GG Oral Treatment Efficacy on Vernal Keratoconjunctivitis Treatment
• Topical Tacrolimus 0.03% Ointment for Intractable Allergic Conjunctivitis: An Open Label Pilot Study
• Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in Allergic Conjunctivitis
• Cyclosporin A Eye Drop Treatment in Vernal Keratoconjunctivitis
• Evaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic Conjunctivitis
• Efficacy and Safety of Topical Bromfenac Ophthalmic Solution vs. Placebo in Subjects With Allergic Conjunctivitis
• Twin SUBLIVAC® Grasses Clinical Efficacy Study
• Efficacy/ Safety of Omalizumab in Patients With Seasonal Allergic Asthma and Seasonal Allergic Rhinoconjunctivitis
• Mast-Cell Stabilizing Effects of Olopatadine
• A Study Of The Safety And Effectiveness Of A New Treatment For Allergic Conjunctivitis
• Evaluation of Efficacy of Ophthalmic Solution in Seasonal Allergic Conjunctivitis
• Study of the Clinical and Biological Efficacity of NAAXIA SINE® in Vernal Keratoconjunctivitis
• Olopatadine 0.2% for the Treatment of Allergic Conjunctivitis
• Efficacy and Tolerance of Nova22007 Versus Vehicle in Patients With Vernal Keratoconjunctivitis (VKC)
• A Study of the Effects of Desloratadine on Conjunctival Allergen Challenge-induced Ocular Signs and Symptoms (Study P04209)
• Use of Probiotic Bacteria in Prevention of Allergic Disease in Children 1999-2008
• Alleviation of Cedar Pollen Induced Allergic Symptoms by Orally Taken Superfine Beta-1,3-Glucan
• Evaluation of Efficacy of Ophthalmic Solution in Induced Allergic Conjunctivitis
• Evaluation of Efficacy of Ophthalmic Solution in Induced Acute Allergic Conjunctivitis
• Safety Study of Ophthalmic Solution in Healthy, Normal Volunteers
• Ketotifen Ophthalmic Solution With Emedastine in Patients With Seasonal Allergic Conjunctivitis